NZSE:MEE

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Me Today Limited, through its subsidiaries, operates as a health and wellness company in New Zealand. More Details


Snowflake Analysis

Flawless balance sheet with weak fundamentals.

Share Price & News

How has Me Today's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: MEE is not significantly more volatile than the rest of NZ stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: MEE's weekly volatility (6%) has been stable over the past year.


Market Performance


7 Day Return

-14.6%

MEE

3.4%

NZ Healthcare

3.9%

NZ Market


1 Year Return

n/a

MEE

7.2%

NZ Healthcare

10.6%

NZ Market

Return vs Industry: Insufficient data to determine how MEE performed against the NZ Healthcare industry.

Return vs Market: Insufficient data to determine how MEE performed against the NZ Market.


Shareholder returns

MEEIndustryMarket
7 Day-14.6%3.4%3.9%
30 Day2.7%2.2%3.2%
90 Day-1.3%9.7%11.0%
1 Yearn/a9.6%7.2%14.7%10.6%
3 Yearn/a69.3%56.9%56.9%36.1%
5 Yearn/a53.4%32.9%112.7%61.1%

Long-Term Price Volatility Vs. Market

How volatile is Me Today's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Me Today undervalued compared to its fair value and its price relative to the market?

4.24x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate MEE's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate MEE's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: MEE is unprofitable, so we can't compare its PE Ratio to the XO Healthcare industry average.

PE vs Market: MEE is unprofitable, so we can't compare its PE Ratio to the NZ market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate MEE's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: MEE is overvalued based on its PB Ratio (4.2x) compared to the NZ Healthcare industry average (2.8x).


Next Steps

Future Growth

How is Me Today forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

17.4%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Me Today has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Me Today performed over the past 5 years?

-132.3%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: MEE is currently unprofitable.

Growing Profit Margin: MEE is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Unable to establish if MEE's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.

Accelerating Growth: Unable to compare MEE's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MEE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-16.1%).


Return on Equity

High ROE: MEE has a negative Return on Equity (-80.41%), as it is currently unprofitable.


Next Steps

Financial Health

How is Me Today's financial position?


Financial Position Analysis

Short Term Liabilities: MEE's short term assets (NZ$8.1M) exceed its short term liabilities (NZ$930.0K).

Long Term Liabilities: MEE's short term assets (NZ$8.1M) exceed its long term liabilities (NZ$154.0K).


Debt to Equity History and Analysis

Debt Level: MEE is debt free.

Reducing Debt: MEE had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MEE has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: MEE has sufficient cash runway for 2.9 years if free cash flow continues to reduce at historical rates of 103.1% each year.


Next Steps

Dividend

What is Me Today current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate MEE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MEE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MEE's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MEE's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MEE's dividend in 3 years as they are not forecast to pay a notable one for the NZ market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.8yrs

Average board tenure


CEO

Michael Kerr

0.83

Tenure

NZ$154,500

Compensation

Mr. Michael Kerr is Co-Founder and has been Director and Chief Executive Officer at Me Today Limited since March 31, 2020. Mr. Kerr has worked in sales and marketing roles for several local and multination...


Board Members

NamePositionTenureCompensationOwnership
Michael Kerr
Co-Founder0.83yrNZ$154.50kno data
Stephen Sinclair
Co-Founder0.83yrNZ$60.00kno data
Grant Baker
Co-Founder & Chairman0.83yrno datano data
Roger Gower
Independent Directorno dataNZ$79.00kno data
Antony Vriens
Independent Director0.83yrno data0.086%
NZ$ 28.3k
Hannah Barrett
Independent Director0.83yrno datano data

0.8yrs

Average Tenure

Experienced Board: MEE's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: MEE only recently listed within the past 12 months.


Top Shareholders

Company Information

Me Today Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Me Today Limited
  • Ticker: MEE
  • Exchange: NZSE
  • Founded: 2018
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: NZ$32.982m
  • Shares outstanding: 412.28m
  • Website: https://www.metoday.com

Number of Employees


Location

  • Me Today Limited
  • Building 10, Level 3
  • 666 Great South Road
  • Auckland
  • 1061
  • New Zealand

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MEENZSE (New Zealand Stock Exchange)YesOrdinary SharesNZNZDApr 2020

Biography

Me Today Limited, through its subsidiaries, operates as a health and wellness company in New Zealand. The company offers range of supplement products from general health to immune function, energy, sleep, ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/01/26 06:01
End of Day Share Price2021/01/26 00:00
Earnings2020/09/30
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.